CAS: 928037-13-2; N-(2-Fluoro-4-((2-(4-(4-Methylpiperazin-1-yl)Piperidine-1-Carboxamido)Pyridin-4-yl)Oxy)Phenyl)-N-(4-Fluorophenyl)Cyclopropane-1,1-Dicarboxamide

• 英文名称N-(2-Fluoro-4-((2-(4-(4-Methylpiperazin-1-yl)Piperidine-1-Carboxamido)Pyridin-4-yl)Oxy)Phenyl)-N-(4-Fluorophenyl)Cyclopropane-1,1-Dicarboxamide
• 中文名称N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺
• IUPAC名称N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
• CAS编号928037-13-2
• MFCD编号:MFCD22124462
• 分子式:C33H37F2N7O4
• 分子量:633.7
• 产品CID: 1966754
• 产品分类生物化工 → 抑制剂 → 蛋白酪氨酸激酶

• 相似结构搜索
• InChIKey: UQRCJCNVNUFYDX-UHFFFAOYSA-N
• InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33…
• 计算化学: 氢键受体数9.0氢键供体数3.0可旋转键数8.0

物理性质

• 熔点187 - 190°C
• 沸点867.5±65.0 °C at 760 mmHg
• 闪点478.5±34.3 °C
• 密度1.4±0.1 g/cm3
• pKa:12.91±0.70(预测)
• PSA:126.12
• LogP:2.03
• 折射率1.671
• 蒸汽压0.0±3.3 mmHg at 25°C
• 溶解性DMSO (Slightly), Methanol (Slightly)
• 外观形态白色至类白色固体
• 储存条件冰箱
• 产品应用该化合物用作抑制C-梅特放大或HGF/VEFF驱动抗力的癌症的肿瘤生长和血管产生;它克服了EGV-FR型强氧酶抑制剂(如GEFITINIB)在EGR-FER型非小型细胞肺癌中引起的抗抗抗药性;它展示了乳腺移植和腹膜肿瘤模型中的抗肿瘤活动,并显示出与GEFATINIB结合导致肿瘤回归的协同效应.

MSDS等安全信息

• GHS符号GHS07
• 警示词Warning
• 危险描述H315-H319-H335
• 防范说明P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P321-P362+P364-P332+P313-P337+P313-P403+P233-P405-P501

上下游产品

合成工艺路线路线简述

• 53617-36-0 = 928037-13-2
  反应条件:1.1 Solvents: Dimethylformamide; 12 H,Rt
  标题:Preparation Of Salts Of 2-Heterocyclylcarbonylamino-4-Phenoxypyridine Derivatives Or Crystals Thereof And Process For Producing The Same
  参考文献:World Intellectual Property Organization]
  
  = 928037-13-2
  反应条件:1.1 Reagents: 4-(4,6-Dimethoxy-1,3,5-Triazin-2-Yl)-4-Methylmorpholinium Chloride Solvents: Dimethylformamide,Tetrahydrofuran; 16 H,Rt1.2 Reagents: Sodium Hydroxide Solvents: Tetrahydrofuran,Water; Neutralized
  标题:Preparation Of Phenoxypyridine Derivatives As Hgfr Inhibitors For Treatment Of Cancer
  参考文献:World Intellectual Property Organization]
  
  53617-36-0 = 928037-13-2
  反应条件:1.1 Solvents: Dimethylformamide; 12 H,Rt
  标题:Novel Pyridine Derivatives And Pyrimidine Derivatives As Hgfr Inhibitors And Their Preparation And Use In The Treatment Of Diseases
  参考文献:United States]
  
  53617-36-0 = 928037-13-2
  反应条件:1.1 Solvents: Dimethylformamide; 12 H,Rt
  标题:Preparation Of Pyridine Or Pyrimidine Derivatives As Antitumor Agents Having Excellent Cell Growth Inhibition Effect And Excellent Antitumor Effect On Cell Strain Having Amplification Of Hgfr Gene
  参考文献:World Intellectual Property Organization]
  
  1009816-49-2 = 928037-13-2
  反应条件:1.1 Reagents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride Solvents: Water; 1 H,15 °C1.2 Reagents: Sodium Hydroxide Solvents: Acetone,Water; Basified
  标题:Preparation Of Phenoxypyridine Derivatives
  参考文献:World Intellectual Property Organization]
  
  1181341-09-2 + 849217-48-7 = 928037-13-2
  反应条件:1.1 Reagents: Triethylamine,O-(7-Azabenzotriazol-1-Yl)-N,N,N′,N′-Tetramethyluronium Hexafluorophosphate Solvents: Dimethylformamide; 21 H,Rt
  标题:Manufacture Of Phenoxypyridine Derivatives
  参考文献:World Intellectual Property Organization]
  
  = 928037-13-2 [标题:Reaction Conditions
  标题:Preparation Of Pyridines And Pyrimidines Having Cyclopropane-1,1-Dicarboxamide Moiety As Hgfr Inhibitors
  参考文献:World Intellectual Property Organization

海关参考信息

• 2912110000-甲醛
  2912120000-乙醛
  2921211000-乙二胺
  2924191000-二甲基甲酰胺
• 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
• 详情请参考：📖 海关编码查询和海关进出口税则

其他信息查阅

• ➥ 象形图和危险代码
• ➥ 防范代码详解
• ➥ 危险代码说明
• ➥ Globally Harmonized System
• ➥ REACH监管